Article Information
History
- April 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yosuke Hirotsua,*,
- Makoto Maejimab,
- Masahiro Shibusawab,
- Yume Natorib,
- Yuki Nagakubob,c,
- Kazuhiro Hosakab,
- Hitomi Suekib,
- Hitoshi Mochizukia,d,e,
- Toshiharu Tsutsuif,
- Yumiko Kakizakif,
- Yoshihiro Miyashitaf and
- Masao Omatae,h
- aGenome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- bDivision of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- cDivision of Genetics and Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- dCentral Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- eDepartment of Gastroenterology, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- fLung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- hThe University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
- ↵*Corresponding author: Yosuke Hirotsu, Genome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan, Post code: 400-8506, Email: hirotsu-bdyu{at}ych.pref.yamanashi.jp, Tel: +81-55-253-7111, Fax: +81-55-253-8011
Posted April 05, 2022.
Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
